Evolva Inc.

UEI: MVJBYJWVMML5
CAGE: 4C998
Primary NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration: Expired Oct 26, 2021

Company facts

Self-certified in SAM.gov: Foreign Owned

For Profit Organization
Entity structure: Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov: 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary
SAM.gov registration date: Apr 4, 2016

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated Apr 3, 2022.

Evolva Inc.'s 4 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award	Agency	Obligated	Awarded
Evolva resveratrol 5KG Contract · N6893619P0113	Naval Air Warfare Center	$16,925	Dec 11, 2018
Nootkatone \| novel toxicant and repellent for arthropod-borne virus vectors (ntravv) Contract · HHSO100201700015C	Office of the Assistant Secretary for Preparedness and Response	$8,348,599	Sep 8, 2017
Evolva INC. Contract Contract · N6893617P0434	Naval Air Warfare Center	$86,000	May 7, 2017
Platform for the production of fesquiterpene aviation fuels and fuel additives from renewable feedstocks Grant · DEAR0000302	Department of Energy	$4,447,890	Apr 11, 2013

Evolva Inc.'s Unique Entity ID (UEI) in SAM.gov is MVJBYJWVMML5.

Evolva Inc.'s CAGE code is 4C998.

Evolva Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Evolva Inc.'s SAM.gov registration expired on October 26, 2021.

Evolva Inc.'s most recent federal contract award is Evolva resveratrol 5KG (N6893619P0113), from Naval Air Warfare Center, on December 11, 2018.

On GovTribe

Try for free Login